Who owns Mersana Therapeutics?
- Ticker: MRSN
- CUSIP Number: 59045l106
Tip: Access positions for across all investors
Analyze quarterly positions in Mersana Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Mersana Therapeutics stock
Who bought or sold Mersana Therapeutics this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
EcoR1 Capital | 19M | $39M | 0% | Jun 2024 |
|
Nextech Invest | 12M | $23M | 27% | Sep 2024 |
|
VR Adviser | 11M | $21M | 0% | Sep 2024 |
|
Bain Capital Life Sciences Investors | 8.7M | $17M | 0% | Jun 2024 |
|
BlackRock | 8.6M | $16M | 100% | Sep 2024 |
|
BlackRock | 8.4M | $17M | 4% | Jun 2024 |
|
Vanguard Group | 6.7M | $14M | 7% | Jun 2024 |
|
Citadel Advisors | 4.5M | $8.4M | 60% | Sep 2024 |
|
Rock Springs Capital Management | 3.0M | $6.1M | 0% | Jun 2024 |
|
State Street Corporation | 2.7M | $5.4M | -51% | Jun 2024 |
|
Cormorant Asset Management | 2.6M | $5.2M | 0% | Jun 2024 |
|
Silverarc Capital Management | 2.5M | $5.0M | -16% | Jun 2024 |
|
Geode Capital Management | 2.4M | $4.6M | -3% | Sep 2024 |
|
Jpmorgan Chase & Co | 2.4M | $4.4M | 19% | Sep 2024 |
|
Morgan Stanley | 2.3M | $4.6M | -23% | Jun 2024 |
|
Schonfeld Strategic Advisors | 2.2M | $4.2M | -25% | Sep 2024 |
|
Boxer Capital | 1.8M | $3.4M | 100% | Sep 2024 |
|
Deutsche Bank Aktiengesellschaft | 1.6M | $3.0M | 1% | Sep 2024 |
|
5AM Venture Management | 1.3M | $2.5M | 0% | Sep 2024 |
|
Goldman Sachs Group | 1.2M | $2.5M | 85% | Jun 2024 |
|
Baker Bros. Advisors | 1.1M | $2.1M | 0% | Sep 2024 |
|
D. E. Shaw & Co | 1.0M | $1.9M | -30% | Sep 2024 |
|
Jacobs Levy Equity Management | 993k | $1.9M | 105% | Sep 2024 |
|
Qube Research & Technologies | 993k | $2.0M | 3% | Jun 2024 |
|
Octagon Capital Advisors | 992k | $1.9M | 0% | Sep 2024 |
|
Bank of America Corporation | 990k | $1.9M | 520% | Sep 2024 |
|
Northern Trust | 934k | $1.8M | -1% | Sep 2024 |
|
Jane Street | 801k | $1.5M | 152% | Sep 2024 |
|
Two Sigma Investments | 749k | $1.5M | 244% | Jun 2024 |
|
Two Sigma Advisers | 719k | $1.4M | 362% | Jun 2024 |
|
HealthInvest Partners AB | 539k | $1.0M | 439% | Sep 2024 |
|
ClariVest Asset Management | 501k | $1.0M | 0% | Sep 2024 |
|
Barclays | 495k | $934k | 33% | Sep 2024 |
|
Renaissance Technologies | 493k | $931k | -66% | Sep 2024 |
|
Bridgeway Capital Management | 476k | $956k | 105% | Jun 2024 |
|
Woodline Partners | 434k | $819k | -70% | Sep 2024 |
|
Bank of New York Mellon | 372k | $703k | -18% | Sep 2024 |
|
Charles Schwab Investment Management | 313k | $591k | 0% | Sep 2024 |
|
Susquehanna Fundamental Investments | 309k | $621k | 32% | Jun 2024 |
|
GSA Capital Partners | 272k | $514k | 369% | Sep 2024 |
|
Squarepoint Ops | 253k | $508k | 100% | Jun 2024 |
|
Bnp Paribas Arbitrage, Snc | 237k | $448k | -29% | Sep 2024 |
|
PanAgora Asset Management | 236k | $475k | 0% | Jun 2024 |
|
Thomas Stevens, CFA" | 190k | $359k | 8% | Sep 2024 |
|
Alliancebernstein | 186k | $374k | 10% | Jun 2024 |
|
Federated Investors | 184k | $347k | -1% | Sep 2024 |
|
683 Capital Management | 183k | $346k | 100% | Sep 2024 |
|
Rhumbline Advisers | 167k | $315k | -5% | Sep 2024 |
|
Susquehanna International | 159k | $301k | -8% | Sep 2024 |
|
Macquarie Group | 150k | $302k | 0% | Jun 2024 |
|
Nuveen Asset Management | 123k | $248k | 0% | Jun 2024 |
|
Superstring Capital Management | 110k | $221k | 100% | Jun 2024 |
|
T. Rowe Price Associates | 99k | $188k | 0% | Sep 2024 |
|
Susquehanna Portfolio Strategies | 94k | $189k | 0% | Jun 2024 |
|
SG Americas Securities | 87k | $165k | -37% | Sep 2024 |
|
Exchange Traded Concepts | 85k | $161k | 96% | Sep 2024 |
|
Citigroup | 82k | $156k | 222% | Sep 2024 |
|
Simplex Trading | 73k | $137k | 88% | Sep 2024 |
|
Algert Coldiron Investors | 64k | $120k | 42% | Sep 2024 |
|
Mirae Asset Global Etfs Holdings | 63k | $119k | 11% | Sep 2024 |
|
QVT Financial | 63k | $126k | 0% | Jun 2024 |
|
Invesco | 56k | $105k | 23% | Sep 2024 |
|
Wells Fargo & Company | 48k | $91k | 2% | Sep 2024 |
|
Manufacturers Life Insurance Company | 47k | $93k | 10% | Jun 2024 |
|
Graham Capital Management | 42k | $80k | -17% | Sep 2024 |
|
Tower Research Capital | 41k | $82k | 4871% | Jun 2024 |
|
Ing Investment Management | 38k | $72k | -1% | Sep 2024 |
|
New York State Common Retirement Fund | 37k | $70k | 0% | Sep 2024 |
|
MetLife Investment Advisors | 34k | $64k | -48% | Sep 2024 |
|
Group One Trading | 33k | $62k | 39% | Sep 2024 |
|
Florida State Board of Administration | 29k | $54k | 0% | Sep 2024 |
|
Intech Investment Management | 27k | $52k | 100% | Sep 2024 |
|
Acadian Asset Management | 24k | $46k | -66% | Sep 2024 |
|
Seaward Management Limited Partnership | 24k | $45k | 0% | Sep 2024 |
|
Jasper Ridge Partners | 23k | $46k | 0% | Jun 2024 |
|
Ohio Pers | 21k | $39k | 0% | Sep 2024 |
|
Us Bancorp | 16k | $31k | 100% | Sep 2024 |
|
Grimes & Company | 15k | $28k | 0% | Sep 2024 |
|
ProShare Advisors | 15k | $30k | -25% | Jun 2024 |
|
Hsbc Holdings | 13k | $25k | -1% | Jun 2024 |
|
Victory Capital Management | 12k | $22k | -3% | Sep 2024 |
|
Royal Bank of Canada | 12k | $25k | 7% | Sep 2024 |
|
Verition Fund Management | 11k | $22k | -98% | Jun 2024 |
|
Caption Management | 10k | $19k | 0% | Sep 2024 |
|
Hunter Perkins Capital Management | 10k | $19k | 0% | Sep 2024 |
|
Summit Investment Advisors | 9.9k | $19k | 0% | Sep 2024 |
|
Russell Investments | 9.5k | $19k | 1% | Jun 2024 |
|
State of Wyoming | 9.2k | $18k | 100% | Jun 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 8.7k | $16k | 0% | Sep 2024 |
|
California State Teachers Retirement System | 8.2k | $16k | 0% | Sep 2024 |
|
Smartleaf Asset Management | 5.3k | $9.7k | 175% | Sep 2024 |
|
Amalgamated Bank | 3.8k | $7.0k | 0% | Sep 2024 |
|
Advisor Group Holdings | 3.4k | $6.5k | -9% | Sep 2024 |
|
NISA Investment Advisors | 3.1k | $5.9k | -82% | Sep 2024 |
|
Picton Mahoney Asset Management | 2.5k | $4.0k | 272% | Sep 2024 |
|
Optiver Holding B.V. | 1.6k | $3.2k | 100% | Jun 2024 |
|
Nordwand Advisors | 1.5k | $2.8k | 0% | Sep 2024 |
|
Sterling Capital Management | 234.00 | $442.002600 | 100% | Sep 2024 |
|
Pnc Financial Services | 200.00 | $378.000000 | 0% | Sep 2024 |
|
Jones Financial Companies, L.L | 200.00 | $370.000000 | 100% | Sep 2024 |
|
North Star Investment Management | 150.00 | $283.995000 | 0% | Sep 2024 |
|
CWM | 125.00 | $0 | 155% | Sep 2024 |
|
Capital Performance Advisors | 11.00 | $21.000100 | 100% | Sep 2024 |
|
Frazier Financial Advisors | 5.00 | $10.000000 | 0% | Sep 2024 |
|
Farther Finance Advisors | 1.00 | $2.000000 | 0% | Sep 2024 |
|
Who sold out of Mersana Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Balyasny Asset Management | Mar 2024 | 3.7M | $16M |
Affinity Asset Advisors | Jun 2024 | 767k | $1.5M |
Millennium Management | Jun 2024 | 692k | $1.4M |
Deep Track Capital | Mar 2024 | 580k | $2.6M |
Rafferty Asset Management | Mar 2024 | 368k | $1.7M |
Hrt Financial | Jun 2024 | 260k | $521k |
Canada Pension Plan Investment Board | Mar 2024 | 205k | $918k |
Marshall Wace | Jun 2024 | 176k | $354k |
XTX Topco | Jun 2024 | 121k | $244k |
Jump Financial | Jun 2024 | 81k | $162k |
ProFund Advisors | Mar 2024 | 58k | $261k |
Aigen Investment Management | Jun 2024 | 50k | $101k |
Y-Intercept | Jun 2024 | 47k | $94k |
AJOVista | Jun 2024 | 21k | $41k |
NEOS Investment Management | Mar 2024 | 20k | $87k |
Principal Financial Group | Jun 2024 | 18k | $37k |
E Fund Management | Mar 2024 | 17k | $78k |
Oxford Asset Management | Mar 2024 | 17k | $74k |
Dimensional Fund Advisors | Jun 2024 | 14k | $28k |
Wolverine Trading | Jun 2024 | 11k | $23k |
Pacer Advisors | Mar 2024 | 1.7k | $7.7k |